Paper - WANFANG MED ONLINE

You Position: Home > Paper

Clinical research and use of radiomics in pancreatic cancer

( views:170, downloads:1 )

Author:: No author available

Journal Title:: Chinese Journal of Pancreatology

Issue:: 6

DOI:: 10.3760/cma.j.cn115667-20211016-00181

Key Word:: 胰腺癌;影像组学;体层摄影术，X线计算机;磁共振成像;诊断

Abstract：影像组学是目前胰腺癌影像领域的研究热点之一，其结合深度学习、人工智能手段已应用于胰腺癌诊断、鉴别诊断、术前评估、疗效评估等方面。本文总结近年来胰腺癌影像组学的研究和应用，旨在为胰腺癌的精准医学研究提供参考。

Reference

[1]Elsa,Parr,Qian,Du,Chi,Zhang,etc.Radiomics-Based Outcome Prediction for Pancreatic Cancer Following Stereotactic Body Radiotherapy.[J].2020,12(4).
[2]Matteo Ligorio,Srinjoy Sil,Jose Malagon-Lopez,etc.Stromal Microenvironment Shapes the Intratumoral Architecture of Pancreatic Cancer[J].2019,178(1).
[3]Farzad,Khalvati,Yucheng,Zhang,Sameer,Baig,etc.Prognostic Value of CT Radiomic Features in Resectable Pancreatic Ductal Adenocarcinoma.[J].2019,9(1).
[4]Yucheng,Zhang,Edrise M,Lobo-Mueller,Paul,Karanicolas,etc.CNN-based survival model for pancreatic ductal adenocarcinoma in medical imaging.[J].2020,20(1).
[5]Liang Liang,Ding Ying,Yu Yiyi,etc.Whole-tumour evaluation with MRI and radiomics features to predict the efficacy of S-1 for adjuvant chemotherapy in postoperative pancreatic cancer patients: a pilot study[J].2021,21(1).
[6]Chen, Xiaojian,Oshima, Kiyoko,Schott, Diane,etc.Assessment of treatment response during chemoradiation therapy for pancreatic cancer based on quantitative radiomic analysis of daily CTs: An exploratory study.[J].2017,12(6).
[7]Yucheng,Zhang,Edrise M,Lobo-Mueller,Paul,Karanicolas,etc.Prognostic Value of Transfer Learning Based Features in Resectable Pancreatic Ductal Adenocarcinoma.[J].2020,3.
[8]Siegel, Rebecca L.,Miller, Kimberly D.,Jemal, Ahmedin.Cancer statistics, 2019[J].2019,69(1).
[9]Matthew H. G. Katz,Jason B. Fleming,Priya Bhosale,etc.Response of borderline resectable pancreatic cancer to neoadjuvant therapy is not reflected by radiographic indicators[J].2012,118(23).
[10]Georgios,Kaissis,Sebastian,Ziegelmayer,Fabian,Lohöfer,etc.A machine learning algorithm predicts molecular subtypes in pancreatic ductal adenocarcinoma with differential response to gemcitabine-based versus FOLFIRINOX chemotherapy.[J].2019,14(10).
[11]Ke,Li,Qiandong,Yao,Jingjing,Xiao,etc.Contrast-enhanced CT radiomics for predicting lymph node metastasis in pancreatic ductal adenocarcinoma: a pilot study.[J].2020,20(1).
[12]Iwatate Yosuke,Hoshino Isamu,Yokota Hajime,etc.Radiogenomics for predicting p53 status, PD-L1 expression, and prognosis with machine learning in pancreatic cancer[J].2020,123(8).
[13].Preoperative/neoadjuvant therapy in pancreatic cancer: a systematic review and meta-analysis of response and resection percentages.[J].2010,7(4).
[14]Na,Chang,Lingling,Cui,Yahong,Luo,etc.Development and multicenter validation of a CT-based radiomics signature for discriminating histological grades of pancreatic ductal adenocarcinoma.[J].2020,10(3).
[15]Linning, E.,Xu, Yan,Wu, Zhifeng,etc.Differentiation of Focal-Type Autoimmune Pancreatitis From Pancreatic Ductal Adenocarcinoma Using Radiomics Based on Multiphasic Computed Tomography[J].2020,44(4).
[16]Bei,Hui,Jia-Jun,Qiu,Jin-Heng,Liu,etc.Identification of Pancreaticoduodenectomy Resection for Pancreatic Head Adenocarcinoma: A Preliminary Study of Radiomics.[J].2020,2020.
[17]Cozzi, Luca,Comito, Tiziana,Fogliata, Antonella,etc.Computed tomography based radiomic signature as predictive of survival and local control after stereotactic body radiation therapy in pancreatic carcinoma.[J].2019,14(1).
[18]Liu Zhaobang,Li Ming,Zuo Changjing,etc.Radiomics model of dual-time 2-[18F]FDG PET/CT imaging to distinguish between pancreatic ductal adenocarcinoma and autoimmune pancreatitis[J].2021,31(9).
[19]Marc A. Attiyeh,Jayasree Chakraborty,Caitlin A. Mclntyre,etc.CT radiomics associations with genotype and stromal content in pancreatic ductal adenocarcinoma[J].2019,44(9).
[20]Bian, Yun,Guo, Shiwei,Jiang, Hui,etc.Relationship Between Radiomics and Risk of Lymph Node Metastasis in Pancreatic Ductal Adenocarcinoma[J].2019,48(9).
[21]Siyuan,Zeng,Marina,Pöttler,Bin,Lan,etc.Chemoresistance in Pancreatic Cancer.[J].2019,20(18).
[22]Yuquan Zhang,Chao Cheng,Zhaobang Liu,etc.Radiomics analysis for the differentiation of autoimmune pancreatitis and pancreatic ductal adenocarcinoma in 18F‐FDG PET/CT[J].2019,46(10).
[23]Muckenhuber, Alexander,Berger, Anne Katrin,Schlitter, Anna Melissa,etc.Pancreatic Ductal Adenocarcinoma Subtyping Using the Biomarkers Hepatocyte Nuclear Factor-1A and Cytokeratin-81 Correlates with Outcome and Treatment Response[J].2018,24(2).
[24]Haidy,Nasief,William,Hall,Cheng,Zheng,etc.Improving Treatment Response Prediction for Chemoradiation Therapy of Pancreatic Cancer Using a Combination of Delta-Radiomics and the Clinical Biomarker CA19-9.[J].2019,9.
[25]Eric A Collisson,Peter Bailey,David K Chang,etc.Molecular subtypes of pancreatic cancer.[J].2019,16(4).
[26]Ming He,Zhenyu Liu,Yusong Lin,etc.Differentiation of atypical non-functional pancreatic neuroendocrine tumor and pancreatic ductal adenocarcinoma using CT based radiomics[J].2019,117.
[27]Baliyan, Vinit,Kordbacheh, Hamed,Parakh, Anushri,etc.Response assessment in pancreatic ductal adenocarcinoma: role of imaging[J].2018,43(2).
[28]Haidy,Nasief,Cheng,Zheng,Diane,Schott,etc.A machine learning based delta-radiomics process for early prediction of treatment response of pancreatic cancer.[J].2019,3.